Teva nears deal for Allergan's generic drugs unit: source

(Reuters) – Teva Pharmaceutical Industries Ltd is in advanced talks to buy Allergan Plc’s generic drug business following a thus far unsuccessful effort to acquire peer Mylan NV , according to a person familiar with the matter.


Leave a Comment

START TYPING AND PRESS ENTER TO SEARCH